Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar

Cardiomyopathy syndrome (CMS) is a severe cardiac disease occurring in the grow-out sea phase of farmed Atlantic salmon with approximately 100 outbreaks annually in Norway. Piscine myocarditis virus (PMCV) is believed to be the causative agent of CMS. There is no vaccine available to control CMS, pa...

Full description

Bibliographic Details
Published in:Aquaculture
Main Authors: Su, Hang, van Eerde, André, Steen, Hege, Heldal, Inger, Haugslien, Sissel, Ørpetveit, Irene, Wüstner, Stefanie Caroline, Inami, Makoto, Løvoll, Marie, Rimstad, Espen, Clarke, Jihong Liu
Format: Article in Journal/Newspaper
Language:English
Published: 2021
Subjects:
Online Access:https://hdl.handle.net/11250/2787033
https://doi.org/10.1016/j.aquaculture.2021.736806
id ftunivmob:oai:nmbu.brage.unit.no:11250/2787033
record_format openpolar
spelling ftunivmob:oai:nmbu.brage.unit.no:11250/2787033 2023-05-15T15:31:35+02:00 Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar Su, Hang van Eerde, André Steen, Hege Heldal, Inger Haugslien, Sissel Ørpetveit, Irene Wüstner, Stefanie Caroline Inami, Makoto Løvoll, Marie Rimstad, Espen Clarke, Jihong Liu 2021-06-02T16:49:27Z application/pdf https://hdl.handle.net/11250/2787033 https://doi.org/10.1016/j.aquaculture.2021.736806 eng eng Aquaculture. 2021, 541 . urn:issn:0044-8486 https://hdl.handle.net/11250/2787033 https://doi.org/10.1016/j.aquaculture.2021.736806 cristin:1913385 10 541 Aquaculture Peer reviewed Journal article 2021 ftunivmob https://doi.org/10.1016/j.aquaculture.2021.736806 2021-10-06T22:37:24Z Cardiomyopathy syndrome (CMS) is a severe cardiac disease occurring in the grow-out sea phase of farmed Atlantic salmon with approximately 100 outbreaks annually in Norway. Piscine myocarditis virus (PMCV) is believed to be the causative agent of CMS. There is no vaccine available to control CMS, partially because PMCV withstands propagation in known cell cultures. In the present study, we selected the putative capsid protein of PMCV as the candidate antigen for immunization experiments and produced it in the plant Nicotiana benthamiana by transient expression. The recombinant PMCV antigen formed virus-like particles (VLPs). To evaluate the efficacy of the plant made VLP vaccine, a PMCV infection model was established. In an experimental salmon vaccination trial, the VLP vaccine triggered innate immunity, and indicative but not significant inhibition of viral replication in heart, spleen and kidney tissues was observed. Similarly, a reduction of inflammatory lesions in cardiomyocytes and subendocardial infiltration by mononuclear leukocytes were observed. Therefore, there was no difference in efficacy or immune response observed post the plant made PMCV VLP antigen vaccination. Taken together, this study has demonstrated that plant made VLP antigens should be investigated further as a possible platform for the development of PMCV antigens for a CMS vaccine. publishedVersion Article in Journal/Newspaper Atlantic salmon Salmo salar Open archive Norwegian University of Life Sciences: Brage NMBU Norway Aquaculture 541 736806
institution Open Polar
collection Open archive Norwegian University of Life Sciences: Brage NMBU
op_collection_id ftunivmob
language English
description Cardiomyopathy syndrome (CMS) is a severe cardiac disease occurring in the grow-out sea phase of farmed Atlantic salmon with approximately 100 outbreaks annually in Norway. Piscine myocarditis virus (PMCV) is believed to be the causative agent of CMS. There is no vaccine available to control CMS, partially because PMCV withstands propagation in known cell cultures. In the present study, we selected the putative capsid protein of PMCV as the candidate antigen for immunization experiments and produced it in the plant Nicotiana benthamiana by transient expression. The recombinant PMCV antigen formed virus-like particles (VLPs). To evaluate the efficacy of the plant made VLP vaccine, a PMCV infection model was established. In an experimental salmon vaccination trial, the VLP vaccine triggered innate immunity, and indicative but not significant inhibition of viral replication in heart, spleen and kidney tissues was observed. Similarly, a reduction of inflammatory lesions in cardiomyocytes and subendocardial infiltration by mononuclear leukocytes were observed. Therefore, there was no difference in efficacy or immune response observed post the plant made PMCV VLP antigen vaccination. Taken together, this study has demonstrated that plant made VLP antigens should be investigated further as a possible platform for the development of PMCV antigens for a CMS vaccine. publishedVersion
format Article in Journal/Newspaper
author Su, Hang
van Eerde, André
Steen, Hege
Heldal, Inger
Haugslien, Sissel
Ørpetveit, Irene
Wüstner, Stefanie Caroline
Inami, Makoto
Løvoll, Marie
Rimstad, Espen
Clarke, Jihong Liu
spellingShingle Su, Hang
van Eerde, André
Steen, Hege
Heldal, Inger
Haugslien, Sissel
Ørpetveit, Irene
Wüstner, Stefanie Caroline
Inami, Makoto
Løvoll, Marie
Rimstad, Espen
Clarke, Jihong Liu
Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar
author_facet Su, Hang
van Eerde, André
Steen, Hege
Heldal, Inger
Haugslien, Sissel
Ørpetveit, Irene
Wüstner, Stefanie Caroline
Inami, Makoto
Løvoll, Marie
Rimstad, Espen
Clarke, Jihong Liu
author_sort Su, Hang
title Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar
title_short Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar
title_full Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar
title_fullStr Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar
title_full_unstemmed Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar
title_sort establishment of a piscine myocarditis virus (pmcv) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (cms) in atlantic salmon salmo salar
publishDate 2021
url https://hdl.handle.net/11250/2787033
https://doi.org/10.1016/j.aquaculture.2021.736806
geographic Norway
geographic_facet Norway
genre Atlantic salmon
Salmo salar
genre_facet Atlantic salmon
Salmo salar
op_source 10
541
Aquaculture
op_relation Aquaculture. 2021, 541 .
urn:issn:0044-8486
https://hdl.handle.net/11250/2787033
https://doi.org/10.1016/j.aquaculture.2021.736806
cristin:1913385
op_doi https://doi.org/10.1016/j.aquaculture.2021.736806
container_title Aquaculture
container_volume 541
container_start_page 736806
_version_ 1766362097957994496